Therapeutic Benefits of Spleen Tyrosine Kinase Inhibitor Administration on Binge Drinking-Induced Alcoholic Liver Injury, Steatosis, and Inflammation in Mice

Alcoholism: Clinical and Experimental Research - United States
doi 10.1111/acer.13096
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Novel Use of N-Acetylcysteine in Management of Tyrosine Kinase Inhibitor Induced Acute Liver Injury

Cureus
2019English

Brown Fat Activation Mitigates Alcohol-Induced Liver Steatosis and Injury in Mice

Journal of Clinical Investigation
Medicine
2019English

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

New England Journal of Medicine
Medicine
2010English

A Spleen Tyrosine Kinase Inhibitor Reduces the Severity of Established Glomerulonephritis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

An Essential Role for Monocyte Chemoattractant Protein-1 in Alcoholic Liver Injury: Regulation of Proinflammatory Cytokines and Hepatic Steatosis in Mice

Hepatology
MedicineHepatology
2011English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

Local Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor May Provide a New Therapeutic Potential for the Treatment of Intractable Upper Airway Inflammation

Journal of Japan Society of Immunology & Allergology in Otolaryngology
2016English

Inhibition of Heat Shock Protein 90 Alleviates Steatosis and Macrophage Activation in Murine Alcoholic Liver Injury

Journal of Hepatology
Hepatology
2014English

CCN1 Promotes Hepatic Steatosis and Inflammation in Non-Alcoholic Steatohepatitis

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy